|Minimum Order Quantity||1.00||Unit of Measure||Piece/Pieces|
|Payment Terms||Paypal, Others||Supply Ability||As Per Requirement Per Week|
|Delivery Time||7-15 Days||Packaging Details||Carton Boxes Packaging.|
|Main Export Market(s)||Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa||Main Domestic Market||All India|
|Export Countries Details:||Countries: Russsia, Ukrain, Romania, Korean, Ajbakistan, Kajistan, Poland, USA, India, Philipines, UK & China||Main Domestic Market||All India|
Hepcinat Suppliers, Exporters, Wholesale Traders & Distributors in India
HEPCINAT contain oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. Chawla Medicos have been setting benchmarks of success in the market as a prominent organization engaged in offering Hepcinat. These are antiviral drug, used in combination with other drugs for treatment of hepatitis C. Our expert agents source Hepcinat tablets from India the trusted and certified vendors of the market. We offer these HEPCINAT Tablets at affordable prices to clients.
- Provide a higher cure rate
- Low indication of side effects
- Effective anti viral drug
Hepcinat Tablets (Sofosbuvir 400 mg)-Generic Sovaldi suppliers, distributors in Delhi, India.
Generic Name: Sofosbuvir
Trade Name: HEPCINAT 400mg Manufactured By NATCO PHARMA LIMITED
Composition: Each film coated tablet contains: Sofosbuvir equivalent to Sofosbuvir 400 mg.
Sofosbuvir 400mg tablets is an antiviral drug which is used in combination with other drugs for treatment of Hepatitis C Virus (HCV) infection. Compared to previous treatments, sofosbuvir based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy.
Mechanism of Action:- Sofosbuvir contains oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. The drug is a direct-acting antiviral agent and interferes straight with the HCV lifecycle, restraining the viral replication. It can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. The drug is available for oral use in the form of HEPCINAT 400mg tablets.
Dosage and Administration: The recommended daily dose of Sofosbuvir is 400 mg tablet to be taken once daily with or without food. Sofosbuvir should be used in combination with Ribavirin or in combination with Pegylated Interferon and Ribavirin for the treatment of CHC (Chronic Hepatitis C) in adults. It is highly advisable to administer the drug under strict medical supervision and advice.
Adverse events associated with the use of Sofosbuvir in combination with Ribavirin may include but are not limited to, the following
Adverse events associated with the use of Sofosbuvir in combination with Peginterferon Alfa and Ribavirin may include, but are not limited to, the following:
Packaging: Each Bottle contains 28 tablets of Sofosbuvir 400 mg.
Storage: Store at 25°C in a dry place.